Value
4.8/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 3.5 |
| Fwd P/E | 1.8 |
| PEG | 10.0 |
| Analyst target | 5.0 |
- ▸Forward P/E: 61.4x
- ▸PEG: 0.29
AXGN · Why this verdict
Why AxoGen (AXGN) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Revenue expanding 27% year-over-year places the company at the top of its industry peer group on growth, and a volume surge of 2.8 times the average on an up-move alongside rising on-balance volume signals institutional accumulation — yet business quality sits just below the minimum acceptable threshold, and the share price trades within 1% of the analyst-derived price target, leaving near-zero reward against meaningful downside.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue grew 27% year-over-year, making this company the growth leader in its industry peer group. The forward earnings multiple near 60x reflects a market that has already priced in a continuation of this expansion, so sustained delivery is essential to justify the premium. Growth breakdown | Revenue growth remains above 20% year-over-year for the next four quarters, validating the current earnings multiple and peer-set ranking. | →Stable |
| CounterA forward P/E near 60x leaves no margin for error; any deceleration would likely trigger sharp multiple compression given the absence of meaningful profitability to anchor the valuation below the growth story. | ||
A golden cross, price above all moving averages, bullish MACD, and a 2.8-times-average volume surge on the recent up-move all signal institutional accumulation. Rising on-balance volume confirms buyers are driving the tape rather than sellers distributing into strength. Momentum breakdown | Price sustains above the 200-day moving average and on-balance volume continues trending higher over the next six months. | →Stable |
| CounterImplied volatility near 138% signals the market is pricing in sharp two-way moves; a single negative catalyst could break the technical pattern quickly in a name of this size and liquidity profile. | ||
Business quality sits just below the minimum acceptable threshold: return on equity and return on assets both register near zero, indicating the company is not yet earning economic returns at scale despite free cash flow of roughly 8% of revenue. Warnings | Quality recovers above the minimum floor within two reporting cycles as operating leverage emerges and returns on capital improve from near-zero levels. | →Stable |
| CounterFree cash flow is positive at an 8% margin despite GAAP losses, and a financial health score that reflects improving discipline suggests the quality gap may close faster than the current score implies. | ||
With the share price within 1% of the analyst-derived price target and a reward-to-risk ratio of roughly 0.1-to-1, the setup offers near-zero upside against roughly 13% potential downside — a structurally unattractive entry geometry regardless of the growth narrative. Price targets | A material analyst target upgrade restores a reward-to-risk ratio above 1.5-to-1, creating a compelling entry geometry for new capital. | →Stable |
| CounterIf the 27% revenue growth continues to beat expectations, analysts may raise targets sharply without requiring a price pullback, quickly restoring a favorable setup. | ||
Revenue grew 27% year-over-year, making this company the growth leader in its industry peer group. The forward earnings multiple near 60x reflects a market that has already priced in a continuation of this expansion, so sustained delivery is essential to justify the premium.
→StableGrowth breakdown
- Expectation
- Revenue growth remains above 20% year-over-year for the next four quarters, validating the current earnings multiple and peer-set ranking.
CounterA forward P/E near 60x leaves no margin for error; any deceleration would likely trigger sharp multiple compression given the absence of meaningful profitability to anchor the valuation below the growth story.
A golden cross, price above all moving averages, bullish MACD, and a 2.8-times-average volume surge on the recent up-move all signal institutional accumulation. Rising on-balance volume confirms buyers are driving the tape rather than sellers distributing into strength.
→StableMomentum breakdown
- Expectation
- Price sustains above the 200-day moving average and on-balance volume continues trending higher over the next six months.
CounterImplied volatility near 138% signals the market is pricing in sharp two-way moves; a single negative catalyst could break the technical pattern quickly in a name of this size and liquidity profile.
Business quality sits just below the minimum acceptable threshold: return on equity and return on assets both register near zero, indicating the company is not yet earning economic returns at scale despite free cash flow of roughly 8% of revenue.
→StableWarnings
- Expectation
- Quality recovers above the minimum floor within two reporting cycles as operating leverage emerges and returns on capital improve from near-zero levels.
CounterFree cash flow is positive at an 8% margin despite GAAP losses, and a financial health score that reflects improving discipline suggests the quality gap may close faster than the current score implies.
With the share price within 1% of the analyst-derived price target and a reward-to-risk ratio of roughly 0.1-to-1, the setup offers near-zero upside against roughly 13% potential downside — a structurally unattractive entry geometry regardless of the growth narrative.
→StablePrice targets
- Expectation
- A material analyst target upgrade restores a reward-to-risk ratio above 1.5-to-1, creating a compelling entry geometry for new capital.
CounterIf the 27% revenue growth continues to beat expectations, analysts may raise targets sharply without requiring a price pullback, quickly restoring a favorable setup.
Per-dimension breakdown
Quality
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 10.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 5.9 |
| FCF quality | 4.5 |
| Moat | 5.8 |
| Rule of 40 | 5.5 |
| Piotroski F | 6.7 |
- ▸FCF-positive despite GAAP loss (FCF margin 8%, FCF yield 0.8%)
Growth
9.6/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 9.1 |
| EPS growth | 10.0 |
- ▸Strong growth: 27% YoY
Momentum
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 7.7 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 7.9 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 7.6 |
| erm sentiment | 5.0 |
Insider
3.9/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 5.1 |
- ▸Modest insider selling — $1,488,412 (0.063% of mkt cap)
Peer rank
2.9/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.8 |
| quality rank | 2.1 |
| growth rank | 8.8 |
- ▸Industry growth leader
Technical
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.5 |
| support resistance | 4.4 |
| 52w position | 8.5 |
Risk (lower is worse)
4.4/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.3 |
| days to cover | 6.7 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 3.0 |
| max pain risk | 3.0 |
| beta | 6.5 |
| debt equity | 0.0 |
- ▸High IV: 62%
- ▸Above max pain $18
Catalyst
6.4/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 5.6 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- MOMENTUM:6.2>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:40d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.3<1.5@spot
Warning (0)
none
Reward-to-Risk
0.35
Upside
+3.9%
Downside
11.2%
Sizing output
AVOID
SetupBREAKOUT — Golden cross, above all MAs, RSI 57, MACD bullish
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $2.4B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Growth at 9.6 could not lift the engine output above the verdict floor. Failed gate signal: ASYMMETRY:0.3<1.5@spot.
The strongest dimensions are Growth at 9.6, Catalyst at 6.4, and Momentum at 6.2; the weakest are Peer rank at 2.9, Quality at 3.8, and Insider at 3.9. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 0.35 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Revenue grew 27% year-over-year, making this company the growth leader in its industry peer group. The forward earnings multiple near 60x reflects a market that has already priced in a continuation of this expansion, so sustained delivery is essential to justify the premium.
Trip ifRevenue growth falls below 15% year-over-year for 2 consecutive quarters.
- P2A golden cross, price above all moving averages, bullish MACD, and a 2.8-times-average volume surge on the recent up-move all signal institutional accumulation. Rising on-balance volume confirms buyers are driving the tape rather than sellers distributing into strength.
Trip ifPrice closes below the 200-day moving average for 3 consecutive sessions.
- P3Business quality sits just below the minimum acceptable threshold: return on equity and return on assets both register near zero, indicating the company is not yet earning economic returns at scale despite free cash flow of roughly 8% of revenue.
Trip ifFree cash flow as a percentage of revenue rises above 15% for 2 consecutive quarters.
- P4With the share price within 1% of the analyst-derived price target and a reward-to-risk ratio of roughly 0.1-to-1, the setup offers near-zero upside against roughly 13% potential downside — a structurally unattractive entry geometry regardless of the growth narrative.
Trip ifReward-to-risk ratio rises above 1.5x following analyst price target revisions that create more than 15% upside from then-current price levels.